Emily English serves as Executive at Cartesian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Emily English has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 28, 2025 involved exercising options for 7,500 shares valued at $24.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 28, 2025 | RNAC | $24.8K | Option Exercise | 7,500 | $3.30 | Discretionary |
Emily English currently holds 62,726 shares of Cartesian Therapeutics, Inc. (RNAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Emily English has been a net neutral trader of RNAC stock. They have purchased $0 and sold $0 worth of shares.
Emily English's most recent insider trade was on Nov 28, 2025, when they sold 7,500 shares at $3.30 per share.
Get notified when new Form 4 filings are submitted